Effects of phytoestrogens on the ovarian and pituitary phenotypes of estrogen-deficient female aromatase knockout mice

Menopause

Volumn 12, Issue 2, 2005, Pages 174-185

  Britt, Kara L ^a,b   Simpson, Evan R ^a   Findlay, Jock K ^a  

^a MONASH UNIVERSITY   (Australia)

^b HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Gonadotropins; Ovarian cysts; Ovary; Phytoestrogen; Sertoli cells

Indexed keywords

FOLLITROPIN; GENISTEIN; GONADOTROPIN; INHIBIN; PHYTOESTROGEN; PROTEIN SUBUNIT; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOYBEAN PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; ESTROGEN THERAPY; EXPERIMENTAL MODEL; GENE EXPRESSION; GENITAL SYSTEM; GENOTYPE; HYPOPHYSIS; KNOCKOUT MOUSE; MORPHOMETRICS; MOUSE; NONHUMAN; ORGAN WEIGHT; OVARY; OVARY CELL; OVARY CYST; PHENOTYPE; PROTEIN DIET; PROTEIN EXPRESSION; SERTOLI CELL; WILD TYPE;

ANIMALS; DIET; DISEASE MODELS, ANIMAL; DNA PRIMERS; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; GENE EXPRESSION; GENISTEIN; GONADOTROPINS; INHIBINS; ISOFLAVONES; MENOPAUSE; MICE; MICE, INBRED AKR; MICE, KNOCKOUT; OVARY; PHENOTYPE; PHYTOESTROGENS; PHYTOTHERAPY; POLYMERASE CHAIN REACTION; SOYBEAN PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; UTERUS;

EID: 16244410131     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042192-200512020-00012     Document Type: Article

References (56)

1. Tham DM, Gardner CD, Haskell WL. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998;83:2223-2235.
2. Reinli K, Block G. Phytoestrogen content of foods-a compendium of literature values. Nutr Cancer 1996;26:123-148.
3. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003;362:419-427.
4. Chlebowski RT, Hendrix SL, Langer RD, et al. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003;289:3243-3253.
5. Adlercreutz H. Diet, breast cancer, and sex hormone metabolism. Ann NY Acad Sci 1990;595:281-290.
6. Messina MJ, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994;21:113-131.
7. Wilcox G, Wahlqvist ML, Burger HG, Medley G. Oestrogenic effects of plant foods in postmenopausal women. BMJ 1990;301:905-906.
8. Cassidy A, Bingham S, Setchell KD. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-340.
9. Cassidy A, Bingham S, Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr 1995;74:587-601.
10. Ososki AL, Kennelly EJ. Phytoestrogens: a review of the present state of research. Phytother Res 2003;17:845-869.
11. Couse JF, Yates MM, Walker VR, Korach KS. Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) Null mice reveals hypergonadism and endocrine sex reversal in females lacking ERα but not ERβ. Mol Endocrinol 2003;17:1039-1053.
12. Britt KL, Stanton PG, Misso ML, Simpson ER, Findlay JK. The effects of estrogen on the expression of genes underlying the differentiation of somatic cells in the murine gonad. Endocrinology 2004;145:3950-3960.
13. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci USA 1998;95:6965-6970.
14. Britt KL, Drummond AE, Cox VA, et al. An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology 2000;141:2614-2623.
15. Britt KL, Kerr J, O'Donnell L, et al. Estrogen regulates development of the somatic cell phenotype in the eutherian ovary. FASEB J 2002;16:1389-1397.
16. Gurr E, ed. Biological Staining Methods. Buckinghamshire, UK; 1973.
17. Groome NP, Illingworth PJ, O'Brien M, et al. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol (Oxf) 1994;40:717-723.
18. Groome NP, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401-1405.
19. Britt KL, Findlay JK. Regulation of the phenotype of ovarian somatic cells by estrogen. Mol Cell Endocrinol 2003;202:11-17.
20. Britt KL, Stanton PG, Misso ML, Jones ME, Simpson ER, Findlay JK. Estrogen modulates the genes underlying the differentiation of somatic cells in the murine gonad. In: The Endocrine Society's 86th Annual Meeting. New Orleans, LA: 2004:707-724.
21. Ito M, Yu R, Jameson JL. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 1997;17:1476-1483.
22. Lalli E, Bardoni B, Zazopoulos E, et al. A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol 1997;11:1950-1960.
23. Zhang H, Thomsen JS, Johansson L, Gustafsson JA, Treuter E. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem 2000;275:39855-39859.
24. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;139:4252-4263.
25. Saunders PT, Maguire SM, Gaughan J, Millar MR. Expression of oestrogen receptor β (ER beta) in multiple rat tissues visualised by immunohistochemistry. J Endocrinol 1997;154:R13-R16.
26. Wang H, Masironi B, Eriksson H, Sahlin L. A comparative study of estrogen receptors alpha and β in the rat uterus. Biol Reprod 1999;61:955-964.
27. Matsuzaki S, Fukaya T, Suzuki T, Murakami T, Sasano H, Yajima A. Oestrogen receptor alpha and β mRNA expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 1999;5:559-564.
28. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-870.
29. Shughrue PJ, Lane MV, Scrimo PJ, Merchenthaler I. Comparative distribution of estrogen receptor-alpha (ER-alpha) and β (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 1998;63:498-504.
30. Byers M, Kuiper GG, Gustafsson JA, Park-Sarge OK. Estrogen receptor-β mRNA expression in rat ovary: down-regulation by gonadotropms. Mol Endocrinol 1997;11:172-182.
31. Fitzpatrick SL, Funkhouser JM, Sindoni DM, et al. Expression of estrogen receptor-β protein in rodent ovary. Endocrinology 1999;140:2581-2591.
32. Sar M, Welsch F. Differential expression of estrogen receptor-β and estrogen receptor-α in the rat ovary. Endocrinology 1999;140:963-971.
33. Mowa CN, Iwanaga T. Differential distribution of oestrogen receptor-α and -β mRNAs in the female reproductive organ of rats as revealed by in situ hybridization. J. Endocrinol 2000;165:59-66.
34. Toda K, Miyaura C, Okada T, Shizuta Y. Dietary bisphenol A prevents ovarian degeneration and bone loss in female mice lacking the aromatase gene (Cyp19). Eur J Biochem 2002;269:2214-2222.
35. Schomberg DW, Couse JF, Mukherjee A, et al. Targeted disruption of the estrogen receptor-alpha gene in female mice: characterization of ovarian responses and phenotype in the adult. Endocrinology 1999;140:2733-2744.
36. Krege JH, Hodgin JB, Couse JF, et al. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A 1998;95:15677-15682.
37. Nagai A, Ikeda Y, Aso T, Eto K, Ikeda MA. Exposure of neonatal rats to diethylstilbestrol affects the expression of genes involved in ovarian differentiation. J Med Dent Sci 2003;50:35-40.
38. Chen G, Shinka T, Kinoshita K, Yan HT, Iwamoto T, Nakahori Y. Roles of estrogen receptor alpha (ER alpha) in the regulation of the human Mullerian inhibitory substance (MIS) promoter. J Med Invest 2003;50:192-198.
39. Akiyama T, Ishida J, Nakagawa S, et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5595.
40. O'Dell TJ, Kandel ER, Grant SG. Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors. Nature 1991;353:558-560.
41. Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991;179:661-667.
42. Magoffin DA, Erickson GF. Direct inhibitory effect of estrogen on LH-stimulated androgen synthesis by ovarian cells cultured in defined medium. Mol Cell Endocrinol 1982;28:81-89.
43. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 1985;6:371-399.
44. Baker PJ, Sha JH, O'Shaughnessy PJ. Localisation and regulation of 17β-hydroxysteroid dehydrogenase type 3 mRNA during development in the mouse testis. Mol Cell Endocrinol 1997;133:127-133.
45. Hughes CL Jr. Effects of phytoestrogens on GnRH-induced luteinizing hormone secretion in ovariectomized rats. Reprod Toxicol 1987;1:179-181.
46. Garcia-Segura LM, Perez J, Tranque PA, Olmos G, Naftolin F. Sexual differentiation of the neuronal plasma membrane: neonatal levels of sex steroids modulate the number of exo-endocytotic images in the developing rat arcuate neurons. Neurosci Lett 1988;91:19-23.
47. Perez J, Luquin S, Naftolin F, Garcia-Segura LM. The role of estradiol and progesterone in phased synaptic remodelling of the rat arcuate nucleus. Brain Res 1993;608:38-44.
48. Clarke IJ. The Hypothalamo-Pituitary Axis. London, UK: W.B. Saunders, 1996.
49. Schwall RH, Mason AJ, Wilcox JN, Bassett SG, Zeleznik AJ. Localization of inhibin/activin subunit mRNAs within the primate ovary. Mol Endocrinol 1990;4:75-79.
50. Pal D, Collins TJ, Parkening TA. Levels of alpha-inhibin in aging female mice. Biol Reprod 1991;45:869-875.
51. Risma KA, Clay CM, Nett TM, Wagner T, Yun J, Nilson JH. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc Natl Acad Sci USA 1995;92:1322-1326.
52. McCartney CR, Eagleson CA, Marshall JC. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome. Semin Reprod Med 2002;20:317-326.
53. Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA 1993;90:11673-11677.
54. Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multi-cystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 1997;82:1739-1745.
55. Casanova M, You L, Gaido KW, Archibeque-Engle S, Janszen DB, Heck HA. Developmental effects of dietary phytoestrogens in Sprague-Dawley rats and interactions of genistein and daidzein with rat estrogen receptors alpha and β in vitro. Toxicol Sci 1999;51:236-244.
56. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr 1998;68:1453S-1461S.